Biomarkers for Colorectal Cancer
AbstractColorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since CRC develops slowly from removable precancerous lesions, detection of the lesion at an early stage by regular health examinations can reduce the incidence and mortality of this malignancy. Colonoscopy significantly improves the detection rate of CRC, but the examination is expensive and inconvenient. Therefore, we need novel biomarkers that are non-invasive to enable us to detect CRC quite early. A number of validation studies have been conducted to evaluate genetic, epigenetic or protein markers for identification in the stool and/or serum. Currently, the fecal occult blood test is the most widely used method of screening for CRC. However, advances in genomics and proteomics will lead to the discovery of novel non-invasive biomarkers. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Tanaka, T.; Tanaka, M.; Tanaka, T.; Ishigamori, R. Biomarkers for Colorectal Cancer. Int. J. Mol. Sci. 2010, 11, 3209-3225.
Tanaka T, Tanaka M, Tanaka T, Ishigamori R. Biomarkers for Colorectal Cancer. International Journal of Molecular Sciences. 2010; 11(9):3209-3225.Chicago/Turabian Style
Tanaka, Takuji; Tanaka, Mayu; Tanaka, Takahiro; Ishigamori, Rikako. 2010. "Biomarkers for Colorectal Cancer." Int. J. Mol. Sci. 11, no. 9: 3209-3225.